Loading…

A comparison of potential psychiatric drug interactions from six drug interaction database programs

•Compared category of potential DDI from 6 drug interaction database programs.•Searched 100 drug interaction pairs containing psychiatric drugs.•Overall percent agreement was 66%; overall Fleiss kappa interrater reliability was fair.•Potential DDI categories from drug interaction database programs o...

Full description

Saved in:
Bibliographic Details
Published in:Psychiatry research 2019-05, Vol.275, p.366-372
Main Authors: Monteith, Scott, Glenn, Tasha
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c394t-3ff6df70ed116730a718c21e13d1d275b19d8f927020c0ad5741030ad07399703
cites cdi_FETCH-LOGICAL-c394t-3ff6df70ed116730a718c21e13d1d275b19d8f927020c0ad5741030ad07399703
container_end_page 372
container_issue
container_start_page 366
container_title Psychiatry research
container_volume 275
creator Monteith, Scott
Glenn, Tasha
description •Compared category of potential DDI from 6 drug interaction database programs.•Searched 100 drug interaction pairs containing psychiatric drugs.•Overall percent agreement was 66%; overall Fleiss kappa interrater reliability was fair.•Potential DDI categories from drug interaction database programs often differ.•When assistance is needed, check more than one drug interaction database program. Harmful drug-drug interactions (DDI) frequently include psychiatric drugs. Drug interaction database programs are viewed as a primary tool to alert physicians of potential DDI, but may provide different results as there is no standard to define DDI. This study compared the category of potential DDI provided by 6 commercial drug interaction database programs (3 subscription, 3 open access) for 100 drug interaction pairs. The pairs involved 94 different drugs; 67 included a psychiatric and non-psychiatric drug, and 33 included two psychiatric drugs. The category assigned to the potential DDI by the 6 programs was compared using percent agreement and Fleiss’ kappa interrater reliability measure. The overall percent agreement for the category of potential DDI for the 100 drug interaction pairs was 66%. The Fleiss kappa overall interrater agreement was fair. The kappa agreement was substantial for interaction pairs with any severe category rating, and fair for interaction pairs with any major category rating. The category of potential DDI for drug interaction pairs including psychiatric drugs often differs among drug interaction database programs. Modern technology allows easy access to several interaction database programs. When assistance from a drug interaction database program is needed, the physician should check more than one program.
doi_str_mv 10.1016/j.psychres.2019.03.041
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2211946787</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0165178119300101</els_id><sourcerecordid>2211946787</sourcerecordid><originalsourceid>FETCH-LOGICAL-c394t-3ff6df70ed116730a718c21e13d1d275b19d8f927020c0ad5741030ad07399703</originalsourceid><addsrcrecordid>eNqFkD1v2zAQhomiRe18_AWDYxcpd6QtilsNo2kCBOjSzgRNnlwalqiSdBD_-yp1kiVDpxvuee_FPYwtEGoEbG729ZhP7neiXAtAXYOsYYkf2BxbJSqFQn5k8wlcVahanLGLnPcAIFDrz2wmEUBCI-fMrbmL_WhTyHHgseNjLDSUYA_8X0GwJQXHfTrueBgKJetKiEPmXYo9z-Hp3Yp7W-zWZuJjirtk-3zFPnX2kOn6ZV6yX7fffm7uqocf3-8364fKSb0sley6xncKyCM2SoJV2DqBhNKjF2q1Re3bTgsFAhxYv1JLnL6wHpTUWoG8ZF_Od6fiP0fKxfQhOzoc7EDxmI0QiHrZqFZNaHNGXYo5J-rMmEJv08kgmGfBZm9eBZtnwQakmQRPwcVLx3Hbk3-LvRqdgK9ngKZPHwMlk12gwZEPiVwxPob_dfwFywKRCQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2211946787</pqid></control><display><type>article</type><title>A comparison of potential psychiatric drug interactions from six drug interaction database programs</title><source>ScienceDirect Journals</source><creator>Monteith, Scott ; Glenn, Tasha</creator><creatorcontrib>Monteith, Scott ; Glenn, Tasha</creatorcontrib><description>•Compared category of potential DDI from 6 drug interaction database programs.•Searched 100 drug interaction pairs containing psychiatric drugs.•Overall percent agreement was 66%; overall Fleiss kappa interrater reliability was fair.•Potential DDI categories from drug interaction database programs often differ.•When assistance is needed, check more than one drug interaction database program. Harmful drug-drug interactions (DDI) frequently include psychiatric drugs. Drug interaction database programs are viewed as a primary tool to alert physicians of potential DDI, but may provide different results as there is no standard to define DDI. This study compared the category of potential DDI provided by 6 commercial drug interaction database programs (3 subscription, 3 open access) for 100 drug interaction pairs. The pairs involved 94 different drugs; 67 included a psychiatric and non-psychiatric drug, and 33 included two psychiatric drugs. The category assigned to the potential DDI by the 6 programs was compared using percent agreement and Fleiss’ kappa interrater reliability measure. The overall percent agreement for the category of potential DDI for the 100 drug interaction pairs was 66%. The Fleiss kappa overall interrater agreement was fair. The kappa agreement was substantial for interaction pairs with any severe category rating, and fair for interaction pairs with any major category rating. The category of potential DDI for drug interaction pairs including psychiatric drugs often differs among drug interaction database programs. Modern technology allows easy access to several interaction database programs. When assistance from a drug interaction database program is needed, the physician should check more than one program.</description><identifier>ISSN: 0165-1781</identifier><identifier>EISSN: 1872-7123</identifier><identifier>DOI: 10.1016/j.psychres.2019.03.041</identifier><identifier>PMID: 31003063</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Clinical decision support systems ; Databases, Factual - statistics &amp; numerical data ; Drug Information Services - statistics &amp; numerical data ; Drug interaction checker ; Drug interaction screening ; Drug interaction software ; Drug Interactions ; Drug-drug interactions ; Humans ; Psychiatric drugs ; Psychotropic Drugs - adverse effects ; Reproducibility of Results</subject><ispartof>Psychiatry research, 2019-05, Vol.275, p.366-372</ispartof><rights>2019 Elsevier B.V.</rights><rights>Copyright © 2019 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c394t-3ff6df70ed116730a718c21e13d1d275b19d8f927020c0ad5741030ad07399703</citedby><cites>FETCH-LOGICAL-c394t-3ff6df70ed116730a718c21e13d1d275b19d8f927020c0ad5741030ad07399703</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31003063$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Monteith, Scott</creatorcontrib><creatorcontrib>Glenn, Tasha</creatorcontrib><title>A comparison of potential psychiatric drug interactions from six drug interaction database programs</title><title>Psychiatry research</title><addtitle>Psychiatry Res</addtitle><description>•Compared category of potential DDI from 6 drug interaction database programs.•Searched 100 drug interaction pairs containing psychiatric drugs.•Overall percent agreement was 66%; overall Fleiss kappa interrater reliability was fair.•Potential DDI categories from drug interaction database programs often differ.•When assistance is needed, check more than one drug interaction database program. Harmful drug-drug interactions (DDI) frequently include psychiatric drugs. Drug interaction database programs are viewed as a primary tool to alert physicians of potential DDI, but may provide different results as there is no standard to define DDI. This study compared the category of potential DDI provided by 6 commercial drug interaction database programs (3 subscription, 3 open access) for 100 drug interaction pairs. The pairs involved 94 different drugs; 67 included a psychiatric and non-psychiatric drug, and 33 included two psychiatric drugs. The category assigned to the potential DDI by the 6 programs was compared using percent agreement and Fleiss’ kappa interrater reliability measure. The overall percent agreement for the category of potential DDI for the 100 drug interaction pairs was 66%. The Fleiss kappa overall interrater agreement was fair. The kappa agreement was substantial for interaction pairs with any severe category rating, and fair for interaction pairs with any major category rating. The category of potential DDI for drug interaction pairs including psychiatric drugs often differs among drug interaction database programs. Modern technology allows easy access to several interaction database programs. When assistance from a drug interaction database program is needed, the physician should check more than one program.</description><subject>Clinical decision support systems</subject><subject>Databases, Factual - statistics &amp; numerical data</subject><subject>Drug Information Services - statistics &amp; numerical data</subject><subject>Drug interaction checker</subject><subject>Drug interaction screening</subject><subject>Drug interaction software</subject><subject>Drug Interactions</subject><subject>Drug-drug interactions</subject><subject>Humans</subject><subject>Psychiatric drugs</subject><subject>Psychotropic Drugs - adverse effects</subject><subject>Reproducibility of Results</subject><issn>0165-1781</issn><issn>1872-7123</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNqFkD1v2zAQhomiRe18_AWDYxcpd6QtilsNo2kCBOjSzgRNnlwalqiSdBD_-yp1kiVDpxvuee_FPYwtEGoEbG729ZhP7neiXAtAXYOsYYkf2BxbJSqFQn5k8wlcVahanLGLnPcAIFDrz2wmEUBCI-fMrbmL_WhTyHHgseNjLDSUYA_8X0GwJQXHfTrueBgKJetKiEPmXYo9z-Hp3Yp7W-zWZuJjirtk-3zFPnX2kOn6ZV6yX7fffm7uqocf3-8364fKSb0sley6xncKyCM2SoJV2DqBhNKjF2q1Re3bTgsFAhxYv1JLnL6wHpTUWoG8ZF_Od6fiP0fKxfQhOzoc7EDxmI0QiHrZqFZNaHNGXYo5J-rMmEJv08kgmGfBZm9eBZtnwQakmQRPwcVLx3Hbk3-LvRqdgK9ngKZPHwMlk12gwZEPiVwxPob_dfwFywKRCQ</recordid><startdate>20190501</startdate><enddate>20190501</enddate><creator>Monteith, Scott</creator><creator>Glenn, Tasha</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20190501</creationdate><title>A comparison of potential psychiatric drug interactions from six drug interaction database programs</title><author>Monteith, Scott ; Glenn, Tasha</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c394t-3ff6df70ed116730a718c21e13d1d275b19d8f927020c0ad5741030ad07399703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Clinical decision support systems</topic><topic>Databases, Factual - statistics &amp; numerical data</topic><topic>Drug Information Services - statistics &amp; numerical data</topic><topic>Drug interaction checker</topic><topic>Drug interaction screening</topic><topic>Drug interaction software</topic><topic>Drug Interactions</topic><topic>Drug-drug interactions</topic><topic>Humans</topic><topic>Psychiatric drugs</topic><topic>Psychotropic Drugs - adverse effects</topic><topic>Reproducibility of Results</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Monteith, Scott</creatorcontrib><creatorcontrib>Glenn, Tasha</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Psychiatry research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Monteith, Scott</au><au>Glenn, Tasha</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A comparison of potential psychiatric drug interactions from six drug interaction database programs</atitle><jtitle>Psychiatry research</jtitle><addtitle>Psychiatry Res</addtitle><date>2019-05-01</date><risdate>2019</risdate><volume>275</volume><spage>366</spage><epage>372</epage><pages>366-372</pages><issn>0165-1781</issn><eissn>1872-7123</eissn><abstract>•Compared category of potential DDI from 6 drug interaction database programs.•Searched 100 drug interaction pairs containing psychiatric drugs.•Overall percent agreement was 66%; overall Fleiss kappa interrater reliability was fair.•Potential DDI categories from drug interaction database programs often differ.•When assistance is needed, check more than one drug interaction database program. Harmful drug-drug interactions (DDI) frequently include psychiatric drugs. Drug interaction database programs are viewed as a primary tool to alert physicians of potential DDI, but may provide different results as there is no standard to define DDI. This study compared the category of potential DDI provided by 6 commercial drug interaction database programs (3 subscription, 3 open access) for 100 drug interaction pairs. The pairs involved 94 different drugs; 67 included a psychiatric and non-psychiatric drug, and 33 included two psychiatric drugs. The category assigned to the potential DDI by the 6 programs was compared using percent agreement and Fleiss’ kappa interrater reliability measure. The overall percent agreement for the category of potential DDI for the 100 drug interaction pairs was 66%. The Fleiss kappa overall interrater agreement was fair. The kappa agreement was substantial for interaction pairs with any severe category rating, and fair for interaction pairs with any major category rating. The category of potential DDI for drug interaction pairs including psychiatric drugs often differs among drug interaction database programs. Modern technology allows easy access to several interaction database programs. When assistance from a drug interaction database program is needed, the physician should check more than one program.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>31003063</pmid><doi>10.1016/j.psychres.2019.03.041</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0165-1781
ispartof Psychiatry research, 2019-05, Vol.275, p.366-372
issn 0165-1781
1872-7123
language eng
recordid cdi_proquest_miscellaneous_2211946787
source ScienceDirect Journals
subjects Clinical decision support systems
Databases, Factual - statistics & numerical data
Drug Information Services - statistics & numerical data
Drug interaction checker
Drug interaction screening
Drug interaction software
Drug Interactions
Drug-drug interactions
Humans
Psychiatric drugs
Psychotropic Drugs - adverse effects
Reproducibility of Results
title A comparison of potential psychiatric drug interactions from six drug interaction database programs
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T19%3A52%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20comparison%20of%20potential%20psychiatric%20drug%20interactions%20from%20six%20drug%20interaction%20database%20programs&rft.jtitle=Psychiatry%20research&rft.au=Monteith,%20Scott&rft.date=2019-05-01&rft.volume=275&rft.spage=366&rft.epage=372&rft.pages=366-372&rft.issn=0165-1781&rft.eissn=1872-7123&rft_id=info:doi/10.1016/j.psychres.2019.03.041&rft_dat=%3Cproquest_cross%3E2211946787%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c394t-3ff6df70ed116730a718c21e13d1d275b19d8f927020c0ad5741030ad07399703%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2211946787&rft_id=info:pmid/31003063&rfr_iscdi=true